APRPG-Conjugated Liposomes
Cat. No.: TDLD-0126-LD314
APRPG-Conjugated Liposomes
APRPG-Conjugated Liposomes are advanced peptide-functionalized liposomes, designed for targeted delivery of therapeutic cargoes like siRNA, mRNA, DNA, small molecule drugs, and RNA-guided gene editing systems. Engineered with APRPG Peptide, a five-amino acid tumor neovasculature-targeting peptide that specifically binds to newly formed blood vessels in tumors, they enhance payload accumulation at tumor sites. Applications include anti-angiogenic cancer therapy research, tumor imaging, targeted delivery of chemotherapeutics or immunotherapeutics to tumor vasculature, and studying tumor angiogenesis biology. Please note that this product is intended for research purposes only.
| Payload Type | Empty; Custom Cargo |
| Module Type | Peptide |
| Targeting Module | APRPG Peptide |
| Liposome Type | Functionalized Liposomes |
| Target | Tumor |
| Lipid Composition | SPC, Chol |
| PEGylation | PEGylated |
| Application | Targeted Delivery |
| Format | Liquid/Lyophilized |
| Size | 50 nm; 100 nm; 200 nm; Others |
| PDI | < 0.3 |
| Zeta | Refer to COA |
| Shipping | Gel Pack |
| Storage |
Liquid: 2°C- 8°C Lyophilized: -20°C |
Click the button below to contact us or submit your feedback about this product.
